Close Menu

NEW YORK – The US Food and Drug Administration has issued new guidance for laboratories and commercial manufacturers with qPCR-based diagnostic tests to detect SARS-CoV-2 virus specifying pathways to authorization for pooled testing indications.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.